UniProtKB/Swiss-Prot Q99959: Variant p.Gln62Lys

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 62 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: US The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Glutamine (Q) to Lysine (K) at position 62 (Q62K, p.Gln62Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and polar (Q) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description: In ARVD9; uncertain significance; decreased protein stability; decreased interaction with DSP; does not affect subcellular location to the desmosomes. Any additional useful information about the variant.
Other resources: Links to websites of interest for the variant.

• Variant rs199601548 [ dbSNP | Ensembl ]

Sequence information

Variant position: 62 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 881 The length of the canonical sequence.
Location on the sequence: GSSGRGGQTVKSLRIQEQVQ Q TLARKGRSSVGNGNLHRTSS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 881	Plakophilin-2
Region	1 – 348	Required for interaction with influenza A virus RNA polymerase subunit PB1
Modified residue	44 – 44	Phosphoserine
Modified residue	46 – 46	Omega-N-methylarginine
Modified residue	82 – 82	Phosphoserine; by MARK3
Mutagenesis	82 – 82	S -> A. Abolishes phosphorylation by MARK3.

Literature citations

Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability.
Hall C.; Li S.; Li H.; Creason V.; Wahl J.K. III;
Cell Commun. Adhes. 16:15-27(2009)
Cited for: INTERACTION WITH DSP; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS ARVD9 LEU-59 AND LYS-62; Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients -- disease-causing or innocent bystanders?
Christensen A.H.; Benn M.; Tybjaerg-Hansen A.; Haunso S.; Svendsen J.H.;
Cardiology 115:148-154(2010)
Cited for: VARIANTS ARVD9 LYS-62; 79-ARG--ASP-881 DEL; ARG-489 AND VAL-673; VARIANTS ASN-26; ASP-58; ILE-70; PHE-140; ALA-338; PRO-366; SER-531 AND ILE-587;